Clinical Trial Update: Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating azithromycin for respiratory failure caused by respiratory syncytial virus in children. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infections

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Respiratory Syncytial Virus Infections | Phase 3 | Status: RECRUITING